Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.
暂无分享,去创建一个
B. Göke | C. Spitzweg | M. Willhauck | J. Morris | S Unterholzner | M J Willhauck | N Cengic | M Schütz | B Göke | J C Morris | C Spitzweg | M. Schütz | N. Cengic | S. Unterholzner
[1] B. Göke,et al. Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter. , 2004, The Journal of clinical endocrinology and metabolism.
[2] L. Riccardi,et al. Effects of ALL‐trans‐retinoic acid and 13‐cis‐retinoic acid on breast‐cancer cell lines: Growth inhibition and apoptosis induction , 1997, International journal of cancer.
[3] John Calvin Reed,et al. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells , 1996, Molecular and cellular biology.
[4] J. Strum,et al. Resting human female breast tissue produces iodinated proteins. , 1983, Journal of Ultrastructure Research.
[5] Qing-Rong Liu,et al. Cloning of the human sodium lodide symporter. , 1996, Biochemical and biophysical research communications.
[6] B. Eskin,et al. Mammary gland dysplasia in iodine deficiency. Studies in rats. , 1967, JAMA.
[7] J. Grippo,et al. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα , 1992, Nature.
[8] C. Spitzweg,et al. The sodium iodide symporter: its pathophysiological and therapeutic implications , 2002, Clinical endocrinology.
[9] D. Mankoff,et al. Cancer: Taking up iodide in breast tissue , 2000, Nature.
[10] R. K. Knight,et al. Prednisolone improves the response to primary endocrine treatment for advanced breast cancer. , 1988, British Journal of Cancer.
[11] L. Dillen,et al. All-trans-retinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cells in vitro. , 1998, British Journal of Cancer.
[12] C. Spitzweg,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Analysis of Human Sodium Iodide Symporter Gene Expression in Extrathyroidal Tissues and Cloning of Its Complementary Deoxyribonucleic Acids from S , 2022 .
[13] W. McGuire,et al. MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors , 1975, Steroids.
[14] N. Etling,et al. Iodinated Compounds and Thyroxine Binding to Albumin in Human Breast Milk , 1984, Pediatric Research.
[15] J. Strum. Site of lodination in rat mammary gland , 1978 .
[16] N. Carrasco,et al. Iodide transport in the thyroid gland. , 1993, Biochimica et biophysica acta.
[17] G. Brent,et al. Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells. , 2005, Endocrinology.
[18] P. Desai,et al. Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: synergy through modulation of interleukin-6 autocrine loop at multiple sites. , 1996, Blood.
[19] B. Eskin. Section of Biological and Medical Sciences: IODINE METABOLISM AND BREAST CANCER*,† , 1970 .
[20] D. Tindall,et al. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells. , 2003, Endocrinology.
[21] R. Vile,et al. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer , 2005, Gene Therapy.
[22] S. Jhiang,et al. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. , 1997, Endocrinology.
[23] P. Roche,et al. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer. , 1999, The Journal of endocrinology.
[24] N. Philp,et al. Iodide transport in a continuous line of cultured cells from rat thyroid. , 1984, Endocrinology.
[25] C. Spitzweg,et al. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. , 1999, The Journal of clinical endocrinology and metabolism.
[26] R. Lotan. Retinoids in cancer chemoprevention , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] R. Mandell,et al. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. , 1999, Cancer research.
[28] S B Kaye,et al. Retinoids: present role and future potential , 1999, British Journal of Cancer.
[29] C. Pellicciari,et al. All-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells. , 1998, British Journal of Cancer.
[30] D. Tindall,et al. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. , 2000, Cancer research.
[31] V. Pallet,et al. Retinoids modulate the binding capacity of the glucocorticoid receptor and its translocation from cytosol to nucleus in liver cells , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[32] D. Walsh,et al. Glucocorticoids in clinical oncology. , 1992, Cleveland Clinic journal of medicine.
[33] B. Göke,et al. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression. , 2005, The Journal of clinical endocrinology and metabolism.
[34] T. Schmidt,et al. Trans-retinoic acid and glucocorticoids synergistically induce transcription from the mouse mammary tumor virus promoter in human embryonic kidney cells , 1997, The Journal of Steroid Biochemistry and Molecular Biology.
[35] N. Carrasco,et al. Na(+)-I- symport activity is present in membrane vesicles from thyrotropin-deprived non-I(-)-transporting cultured thyroid cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[36] D. Edwards,et al. Coregulatory proteins in nuclear hormone receptor action. , 1999, Vitamins and hormones.
[37] F. Moatamed,et al. Systemic Retinoic Acid Treatment Induces Sodium/Iodide Symporter Expression and Radioiodide Uptake in Mouse Breast Cancer Models , 2004, Cancer Research.
[38] T. Nagaya,et al. Glucocorticoids increase retinoid-X receptor alpha (RXRalpha) expression and enhance thyroid hormone action in primary cultured rat hepatocytes. , 1999, Journal of molecular endocrinology.
[39] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[40] M. Matsubara,et al. Retinoic acids and thyroid hormone act synergistically with dexamethasone to increase growth hormone-releasing hormone receptor messenger ribonucleic acid expression. , 2000, Endocrinology.
[41] M. Pfahl,et al. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors , 1992, Nature.
[42] N. Carrasco,et al. Cloning and characterization of the thyroid iodide transporter , 1996, Nature.
[43] C. Glass,et al. RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements , 1991, Cell.
[44] E. McDermott,et al. Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer. , 2000, The Journal of clinical endocrinology and metabolism.
[45] M. Akashi,et al. Effect of Ligands of Nuclear Hormone Receptors on Sodium/Iodide Symporter Expression and Activity in Breast Cancer Cells , 2003, Breast Cancer Research and Treatment.
[46] N. Philp,et al. Effect of thyrotropin on iodide efflux in FRTL-5 cells mediated by Ca2+. , 1984, Endocrinology.
[47] B. Vennström,et al. Binding characteristics of the thyroid hormone receptor homo- and heterodimers to consensus AGGTCA repeat motifs. , 1992, Molecular endocrinology.
[48] G. Brent,et al. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[49] T. Imai,et al. Suppressive effect of iodine on DMBA‐induced breast tumor growth in the rat , 1996, Journal of surgical oncology.
[50] Gregor Eichele,et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor , 1992, Cell.
[51] A. Fischer,et al. An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues. , 1998, Endocrinology.
[52] G. Hortobagyi,et al. Treatment of breast cancer. , 1998, The New England journal of medicine.
[53] D. Tindall,et al. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. , 1999, Cancer research.
[54] M. Lippman,et al. The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. , 1976, Cancer research.
[55] R. K. Knight,et al. Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer. , 1982, European journal of cancer & clinical oncology.
[56] D. Tindall,et al. In vivo sodium iodide symporter gene therapy of prostate cancer , 2001, Gene Therapy.
[57] S. Fineberg,et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer , 2000, Nature Medicine.
[58] R. Chlebowski. Reducing the risk of breast cancer. , 2000, The New England journal of medicine.
[59] O. Spydevold,et al. Retinoid X receptor (RXR alpha) gene expression is regulated by fatty acids and dexamethasone in hepatic cells. , 1997, Biochimie.